» Articles » PMID: 31196158

Fibrosis-4 Index at Diagnosis is Associated with All-cause Mortality in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis

Overview
Publisher Biomed Central
Specialty Gastroenterology
Date 2019 Jun 15
PMID 31196158
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The fibrosis-4 index (FIB-4) has been reported to be associated with all-cause mortality in several chronic diseases. In this study, we investigated whether at diagnosis could be associated with all-cause mortality in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).

Methods: We retrospectively reviewed the medical records of 132 MPA and GPA patients without chronic liver diseases. Conventional risk factors included old age (≥ 65 years), male gender, diabetes mellitus (DM) and hypertension (HTN) at diagnosis, and disease-related risk factor included GPA, antineutrophil cytoplasmic antibody, Birmingham vasculitis activity score (BVAS) and five factor score (FFS (2009)). The cut-off of FIB-4 for significant liver fibrosis (S2-4) was set at 1.45.

Results: The mean age was 57.2 years and 27 patients (20.5%) had significant liver fibrosis (FIB-4 ≥ 1.45). Fifteen patients (11.4%) died during follow-up. In the univariable Cox Hazards model, age ≥ 65 years (Hazard ratio (HR) 5.055), DM (HR 3.446), HTN (HR 4.611), FFS (2009) ≥ 2 (HR 4.849) and FIB-4 ≥ 1.45 (HR 9.958) at diagnosis were significantly associated with all-cause mortality. In the multivariable Cox Hazards model, only FIB-4 at diagnosis ≥1.45 (HR 6.253, 95% confidence interval 1.398, 27.963) was associated with all-cause mortality during the follow-up in patients with MPA and GPA.

Conclusions: FIB-4 at diagnosis ≥1.45 is an independent predictor of all-cause mortality during follow-up in patients with MPA and GPA, and furthermore its predictive potential is higher than those of conventional and AAV-related risk factors for all-cause mortality.

Citing Articles

Fibrosis-4 index is closely associated with future development of hypertension in the Japanese general population.

Yamashita S, Takase H, Kawakatsu N, Hayashi K, Kin F, Isogaki T Hypertens Res. 2024; 48(2):796-804.

PMID: 39639128 DOI: 10.1038/s41440-024-02028-4.


A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches.

Giangregorio F, Mosconi E, Debellis M, Provini S, Esposito C, Garolfi M J Clin Med. 2024; 13(19).

PMID: 39407941 PMC: 11478146. DOI: 10.3390/jcm13195880.


Fibrosis-4 Score Is Associated with Mortality in Hemodialysis Patients with Chronic Viral Hepatitis: A Retrospective Study.

Liu H, Yen C, Jeng W, Hung C, Hsiao C, Tian Y Diagnostics (Basel). 2024; 14(18).

PMID: 39335727 PMC: 11431842. DOI: 10.3390/diagnostics14182048.


Hepatic steatosis index at diagnosis has the potential for forecasting end-stage kidney disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Choi H, Park P, Park Y, Huh J, Lee S, Ph D J Rheum Dis. 2023; 30(4):260-267.

PMID: 37736592 PMC: 10509637. DOI: 10.4078/jrd.2023.0032.


Non-alcoholic fatty liver disease fibrosis score is a useful index for predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Whang J, Park P, Park Y, Huh J, Lee S Front Med (Lausanne). 2023; 10:1217937.

PMID: 37711740 PMC: 10497776. DOI: 10.3389/fmed.2023.1217937.


References
1.
Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W . Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2006; 66(2):222-7. PMC: 1798520. DOI: 10.1136/ard.2006.054593. View

2.
Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V . FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007; 46(1):32-6. DOI: 10.1002/hep.21669. View

3.
Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S . Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2008; 68(12):1827-32. DOI: 10.1136/ard.2008.101279. View

4.
Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P . The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011; 90(1):19-27. DOI: 10.1097/MD.0b013e318205a4c6. View

5.
Yamagata K, Usui J, Saito C, Yamaguchi N, Hirayama K, Mase K . ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol. 2012; 16(4):580-8. DOI: 10.1007/s10157-012-0598-2. View